nach oben

Erschienen in:

01.02.2023 | Clinical study

DMARD retention rates lower in patients with RA with interstitial lung disease

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Disease-modifying antirheumatic drug (DMARD) retention rates are lower in patients with rheumatoid arthritis (RA) with interstitial lung disease (ILD) than in those without ILD, according to findings of South Korean study published in BioDrugs . …

Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study BioDrugs : 9 Feb 2023. Available from: URL: https://doi.org/10.1007/s40259-023-00578-6

Titel: DMARD retention rates lower in patients with RA with interstitial lung disease
Publikationsdatum: 01.02.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-33526-5

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Antiretrovirals

Progesterone

Corticosteroids/cyclophosphamide

Diazepam/metoclopramide

Methylprednisolone

Multiple drugs